194 related articles for article (PubMed ID: 21544866)
1. A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover.
Horwitz MJ; Tedesco MB; Sereika SM; Prebehala L; Gundberg CM; Hollis BW; Bisello A; Garcia-Ocaña A; Carneiro RM; Stewart AF
J Bone Miner Res; 2011 Sep; 26(9):2287-97. PubMed ID: 21544866
[TBL] [Abstract][Full Text] [Related]
2. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
Horwitz MJ; Tedesco MB; Sereika SM; Syed MA; Garcia-Ocaña A; Bisello A; Hollis BW; Rosen CJ; Wysolmerski JJ; Dann P; Gundberg C; Stewart AF
J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737
[TBL] [Abstract][Full Text] [Related]
3. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH(1-34) in humans.
Everhart-Caye M; Inzucchi SE; Guinness-Henry J; Mitnick MA; Stewart AF
J Clin Endocrinol Metab; 1996 Jan; 81(1):199-208. PubMed ID: 8550752
[TBL] [Abstract][Full Text] [Related]
5. A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: the PrOP study.
Horwitz MJ; Augustine M; Khan L; Martin E; Oakley CC; Carneiro RM; Tedesco MB; Laslavic A; Sereika SM; Bisello A; Garcia-Ocaña A; Gundberg CM; Cauley JA; Stewart AF
J Bone Miner Res; 2013 Nov; 28(11):2266-76. PubMed ID: 23661240
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis.
Plotkin H; Gundberg C; Mitnick M; Stewart AF
J Clin Endocrinol Metab; 1998 Aug; 83(8):2786-91. PubMed ID: 9709948
[TBL] [Abstract][Full Text] [Related]
7. Effects of infusion of human parathyroid hormone-related protein-(1-40) in nude mice: histomorphometric and biochemical investigations.
Rosol TJ; Capen CC; Horst RL
J Bone Miner Res; 1988 Dec; 3(6):699-706. PubMed ID: 2855193
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man.
Fraher LJ; Hodsman AB; Jonas K; Saunders D; Rose CI; Henderson JE; Hendy GN; Goltzman D
J Clin Endocrinol Metab; 1992 Aug; 75(2):417-23. PubMed ID: 1322424
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy.
Syed MA; Horwitz MJ; Tedesco MB; Garcia-Ocaña A; Wisniewski SR; Stewart AF
J Clin Endocrinol Metab; 2001 Apr; 86(4):1525-31. PubMed ID: 11297578
[TBL] [Abstract][Full Text] [Related]
10. Exogenous PTH-related protein and PTH improve mineral and skeletal status in 25-hydroxyvitamin D-1alpha-hydroxylase and PTH double knockout mice.
Xue Y; Zhang Z; Karaplis AC; Hendy GN; Goltzman D; Miao D
J Bone Miner Res; 2005 Oct; 20(10):1766-77. PubMed ID: 16160734
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-related protein induced coupled increases in bone formation and resorption markers for 7 years in a patient with malignant islet cell tumors.
Takeuchi Y; Fukumoto S; Nakayama K; Tamura Y; Yanagisawa A; Fujita T
J Bone Miner Res; 2002 May; 17(5):753-7. PubMed ID: 12009004
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone-related protein for the treatment of postmenopausal osteoporosis: defining the maximal tolerable dose.
Horwitz MJ; Tedesco MB; Garcia-Ocaña A; Sereika SM; Prebehala L; Bisello A; Hollis BW; Gundberg CM; Stewart AF
J Clin Endocrinol Metab; 2010 Mar; 95(3):1279-87. PubMed ID: 20061412
[TBL] [Abstract][Full Text] [Related]
13. Effects of continuous infusion of parathyroid hormone and parathyroid hormone-related peptide on rat bone in vivo: comparative study by histomorphometry.
Kitazawa R; Imai Y; Fukase M; Fujita T
Bone Miner; 1991 Mar; 12(3):157-66. PubMed ID: 2021707
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone-related protein-(1-36) is biologically active when administered subcutaneously to humans.
Henry JG; Mitnick M; Dann PR; Stewart AF
J Clin Endocrinol Metab; 1997 Mar; 82(3):900-6. PubMed ID: 9062504
[TBL] [Abstract][Full Text] [Related]
15. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by human interleukin-1 alpha of parathyroid hormone-related peptide effects on renal calcium and phosphorus metabolism in the rat.
Tørring O; Turner RT; Carter WB; Firek AF; Jacobs CA; Heath H
Endocrinology; 1992 Jul; 131(1):5-13. PubMed ID: 1319327
[TBL] [Abstract][Full Text] [Related]
17. Interactions of growth hormone and parathyroid hormone in renal phosphate, calcium, and calcitriol metabolism and bone remodeling in postmenopausal women.
Lieberman SA; Holloway L; Marcus R; Hoffman AR
J Bone Miner Res; 1994 Nov; 9(11):1723-8. PubMed ID: 7863823
[TBL] [Abstract][Full Text] [Related]
18. Synthetic parathyroid hormone-like protein (1-74) is anabolic for bone in vivo.
Weir EC; Terwilliger G; Sartori L; Insogna KL
Calcif Tissue Int; 1992 Jul; 51(1):30-4. PubMed ID: 1393774
[TBL] [Abstract][Full Text] [Related]
19. Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism.
Dobnig H; Kainer F; Stepan V; Winter R; Lipp R; Schaffer M; Kahr A; Nocnik S; Patterer G; Leb G
J Clin Endocrinol Metab; 1995 Dec; 80(12):3699-707. PubMed ID: 8530622
[TBL] [Abstract][Full Text] [Related]
20. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
